Alembic Pharma gets USFDA nod for overactive bladder treatment drug

The company has received approval from the USFDA for its abbreviated new drug application (ANDA) Solifenacin Succinate tablets in the strengths of 5 mg and 10 mg.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/30zFt9R
via Latest News of India